Martin Capital Partners, LLC Gilead Sciences, Inc. Transaction History

Martin Capital Partners, LLC

$202 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 05, 2024	SELL	$73.27 - $83.09 $32,751 - $37,141	-447 Reduced 1.08%	41,064 $3.33 Million
Q3 2023 Oct 13, 2023	BUY	$73.94 - $80.67 $38,005 - $41,464	514 Added 1.25%	41,511 $3.11 Million
Q2 2023 Jul 17, 2023	SELL	$76.01 - $86.7 $53,891 - $61,470	-709 Reduced 1.7%	40,997 $3.16 Million
Q1 2023 Apr 05, 2023	SELL	$77.31 - $88.08 $1.97 Million - $2.25 Million	-25,531 Reduced 37.97%	41,706 $3.46 Million
Q4 2022 Jan 05, 2023	BUY	$62.32 - $89.47 $84,755 - $121,679	1,360 Added 2.06%	67,237 $5.77 Million
Q3 2022 Oct 06, 2022	BUY	$59.54 - $68.01 $138,549 - $158,259	2,327 Added 3.66%	65,877 $4.06 Million
Q2 2022 Jul 08, 2022	BUY	$57.72 - $65.01 $97,719 - $110,061	1,693 Added 2.74%	63,550 $3.93 Million
Q1 2022 Apr 06, 2022	BUY	$57.92 - $72.58 $152,677 - $191,320	2,636 Added 4.45%	61,857 $3.68 Million
Q4 2021 Jan 07, 2022	BUY	$64.88 - $73.64 $41,847 - $47,497	645 Added 1.1%	59,221 $4.3 Million
Q3 2021 Oct 06, 2021	BUY	$67.69 - $73.03 $30,595 - $33,009	452 Added 0.78%	58,576 $4.09 Million
Q2 2021 Jul 06, 2021	BUY	$63.47 - $69.35 $62,771 - $68,587	989 Added 1.73%	58,124 $4 Million
Q1 2021 Apr 14, 2021	BUY	$60.0 - $68.46 $553,320 - $631,338	9,222 Added 19.25%	57,135 $3.69 Million
Q4 2020 Jan 07, 2021	SELL	$56.65 - $64.55 $50,078 - $57,062	-884 Reduced 1.81%	47,913 $2.79 Million
Q3 2020 Oct 08, 2020	SELL	$62.1 - $78.08 $25,212 - $31,700	-406 Reduced 0.83%	48,797 $3.08 Million
Q2 2020 Jul 07, 2020	SELL	$72.34 - $84.0 $780,765 - $906,612	-10,793 Reduced 17.99%	49,203 $3.79 Million
Q1 2020 Apr 21, 2020	SELL	$62.63 - $80.22 $28,183 - $36,099	-450 Reduced 0.74%	59,996 $4.49 Million
Q4 2019 Jan 31, 2020	BUY	$61.62 - $67.78 $1.59 Million - $1.75 Million	25,817 Added 74.55%	60,446 $3.93 Million
Q3 2019 Nov 20, 2019	BUY	$62.51 - $69.0 $2.16 Million - $2.39 Million	34,629 New	34,629 $2.2 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Martin Capital Partners, LLC with notifications on news.

Account